Metropolis Healthcare reports 15% growth in core business revenue during Q4FY24

12 Apr 2024 Evaluate

Metropolis Healthcare has reported around 15% growth Year-on-Year (Y-o-Y) in core business revenue during fourth quarter of FY24. Its core revenue growth was driven by volume growth around 8% and Revenue Per Patient (RPP) growth at 7% YoY for Q4FY24. RPP growth was largely driven by growth in speciality tests segment, premium wellness segment and price increase. The company’s Business-to-Consumer (B2C) revenue grew at around 18% Y-o-Y for Q4FY24. Meanwhile, the company has become debt-free in Q4FY24.  

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Metropolis Health. Share Price

2131.90 -42.70 (-1.96%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7236.35
Max Healthcare Inst 1193.20
Narayana Hrudayalay 1280.95
Aster DM Healthcare 494.95
Global Health 1133.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.